NPR continues its examination of medical marijuana: "Fourteen states and the District of Columbia have launched a medical experiment that doesn't follow any of the rules of science. By approving the use of marijuana as a medicine - with varying kinds of restrictions - these jurisdictions are...
Taro Pharmaceutical Industries Ltd. ("Taro," the "Company," Pink Sheets: TAROF) reported this week that it has received approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application for Granisetron Hydrochloride Tablets USP, 1 mg (base) ("granisetron...
Prolia, a new injectable drug to treat osteoporosis in postmenopausal women at high risk of fractures has been approved by the US Food and Drug Administration (FDA). In a statement on its website on 1st June, the federal agency announced that approving Prolia, made by Amgen, offers...
Repligen Corporation (Nasdaq: RGEN) announced that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company's proposal to re-analyze the images from our Phase 3 study to establish the utility of RG1068, synthetic human secretin, in improving...
Impax Laboratories, Inc. (NASDAQ: IPXL) today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application (ANDA) for generic version of Opana® ER (oxymorphone hydrochloride) 5, 7.5, 10, 15, 20, 30 and 40 mg tablets...
Boston Scientific Corporation (NYSE: BSX) announced U.S. Food and Drug Administration (FDA) approval for LATITUDE 6.0, a software upgrade to the Company's LATITUDE® Patient Management system. The LATITUDE system enables physicians to remotely monitor patients with implantable cardiac devices...
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, announced FDA approval of bacitracin for injection, USP (bacitracin), an anti-infective product used to treat pneumonia and empyema. Bacitracin will be offered in a 50,000 MU, AP-rated, preservative-free...
Following news of the acquisition of BioForm Medical, Inc. earlier this year, Merz Aesthetics, the new business unit of Merz Pharma Group, makes its debut at the prestigious American Society of Aesthetic Plastic Surgeons (ASAPS) annual meeting with the announcement of the U.S. Food and Drug...
...Please help!!? I have been experiencing this problem for some months. I had 40 people on my request list but every few days the total reduces by 1 or 2 and they get added onto my list of friends without my approval!!! I have changed my password twice but to no avail. Some have suggested it...
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) and Alexion Pharma International Sarl today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved the Company's New Drug Application (NDA) for the use of Soliris® (eculizumab) as a treatment for patients in Japan with...
Santen Pharmaceutical Co., Ltd. (TOKYO: 4536) and Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that the Japanese Ministry of Health, Labour and Welfare granted approval for the new dry eye treatment drug, DIQUAS Ophthalmic Solution 3% (generic name: diquafosol tetrasodium), on...
BioAlliance Pharma SA (Euronext Paris - BIO) (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, announces today the approval by the US FDA (Food and Drug Administration) of Oravig® (miconazole Lauriad®, known as Loramyc® in Europe) for the...
The You're Not Helping Blog, a blog written by a consortium of well known bloggers with the assigned task of determining which bloggers, and which blog posts, "help" vs. "not help" has certified certain things said by PZ Myres and Michael Ruse as .... A-OK!
Check it out:
Read the rest of...
The You're Not Helping Blog, a blog written by a consortium of well known bloggers with the assigned task of determining which bloggers, and which blog posts, "help" vs. "not help" has certified certain things said by PZ Myres and Michael Ruse as .... A-OK!
Check it out:
Read the rest of...
Akorn, Inc. (NASDAQ: AKRX) a niche generic pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of Dilaudid-HP® 10mg/ml Injection. The company intends to begin...
The You're Not Helping Blog, a blog written by a consortium of well known bloggers with the assigned task of determining which bloggers, and which blog posts, "help" vs. "not help" has certified certain things said by PZ Myres and Michael Ruse as .... A-OK!
Check it out:
Read the rest of...
Akorn, Inc. (NASDAQ: AKRX) a niche generic pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of Dilaudid-HP® 10mg/ml Injection. The company intends to begin...
The You're Not Helping Blog, a blog written by a consortium of well known bloggers with the assigned task of determining which bloggers, and which blog posts, "help" vs. "not help" has certified certain things said by PZ Myres and Michael Ruse as .... A-OK!
Check it out:
Read the rest of...
Akorn, Inc. (NASDAQ: AKRX) a niche generic pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of Dilaudid-HP® 10mg/ml Injection. The company intends to begin...
Baxter International Inc. (NYSE: BAX) and Nycomed announced the U.S. Food and Drug Administration (FDA) approval of TachoSil (Absorbable Fibrin Sealant Patch) for use as an adjunct to hemostasis in cardiovascular surgery. TachoSil is the first and only adjunctive hemostatic agent available in...